|
|
|
|
| LEADER |
00000caa a22000002c 4500 |
| 001 |
1912737507 |
| 003 |
DE-627 |
| 005 |
20250115055037.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
241217s2016 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1186/s12919-016-0070-5
|2 doi
|
| 035 |
|
|
|a (DE-627)1912737507
|
| 035 |
|
|
|a (DE-599)KXP1912737507
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 084 |
|
|
|a 2,1
|2 ssgn
|
| 100 |
1 |
|
|a Gregg, Edward W.
|e VerfasserIn
|4 aut
|
| 245 |
1 |
4 |
|a The U.S. Diabetes Surveillance System: Lessons and Applications for Health Policy
|
| 264 |
|
1 |
|b Robert Koch Institut
|c 2016
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 655 |
|
4 |
|a Konferenzschrift ; 2016 ; Berlin, Germany
|
| 700 |
1 |
|
|a Geiss, Linda
|e VerfasserIn
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Development of a National Diabetes Surveillance System in Germany--Core Indicators and Conceptual Framework
|
| 856 |
|
|
|u https://bmcproc.biomedcentral.com/track/pdf/10.1186/s12919-016-0070-5
|x unpaywall
|z Vermutlich kostenfreier Zugang
|h publisher [oa journal (via doaj)]
|
| 856 |
4 |
0 |
|u https://doi.org/10.1186/s12919-016-0070-5
|x Resolving-System
|z kostenfrei
|3 Volltext
|
| 935 |
|
|
|a mkri
|
| 951 |
|
|
|a AR
|
| ELC |
|
|
|a 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 4637703069
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1912737507
|
| LOK |
|
|
|0 005 20241217045117
|
| LOK |
|
|
|0 008 241217||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 035
|a (DE-2619)ICPSR144779
|
| LOK |
|
|
|0 040
|a DE-2619
|c DE-627
|d DE-2619
|
| LOK |
|
|
|0 092
|o n
|
| LOK |
|
|
|0 852
|a DE-2619
|
| LOK |
|
|
|0 852 1
|9 00
|
| LOK |
|
|
|0 935
|a uvkn
|a nacp
|
| OAS |
|
|
|a 1
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
